Publications & Abstracts
Do quantitative levels of antispike-IgG antibodies aid in predicting protection from SARS-CoV-2 infection? Results from a longitudinal study in a police cohort
Sendi P, Widmer N, Branca M,
Thierstein M, Büchi AE, Güntensperger D, Blum MR, Baldan R, Tinguely C, Heg D, Theel ES, Berbari
E, Tande AJ, Endimiani A, Gowland P, Niederhauser C; PoliCOV-19 study J Med Virol. 2023
Jul;95(7): e28904. https://doi.org/10.1002/jmv.28904Neuropathies related to hepatitis E virus infection: A prospective, matched case–control study
Ripellino R, Lascano AM, Scheidegger O, Schilg-Hafer L, Schreiner B, Tsouni P, Vicino A, Peyer AK,
Humm A, Décard BF, Pianezzi E, Zezza G, Sparasci D, Hundsberger T, Dietmann A, Jung H, Kuntzer
T, Wilder-Smith E, Martinetti-Lucchini G, Petrini O, Fontana S, Gowland P, Niederhauser C, Gobbi
C. European Journal of Neurology. https://doi.org/10.1111/ene.16030Versorgung von Patienten mit seltenen Blutgruppen (Prise en charge des patients présentants des groupes sanguins rares
Blanc C, Münger S, Lejon Crottet S, Still F. Labmag 8-9 / 2023; 213-218.
Epidemiology of HEV Infection in Blood Donors in Southern Switzerland. Fontana S, Ripellino P,
Niederhauser C, Widmer N, Gowland P, Petrini O, Aprile M, Merlani G and Bihl F. Microorganisms
2023, 11, 2375. https://doi.org/10.3390/microorganisms11102375Fetal RHD Screening in RH1 Negative Pregnant Women: Experience in Switzerland
Schimanski B, Kräuchi R , Stettler J , Lejon Crottet S , Niederhauser C , Banch Clausen F, Fontana S, Hodel
M, Amylidi-Mohr S, Raio L, Abbal C and Henny C. Biomedicines 2023, 11, 2646.
https://doi.org/10.3390/biomedicines11102646"Don't add fuel to the fire"- Hyperhemolysis Syndrome in a pregnant woman with compound Sickle cell disease/ß0-thalassemia - Case report and review of the literature
Rihsling A, Simeunovic H, Sanchez S, Henny C, Lejon Crottet S, Mansouri Teleghani B, Daskalakis
M, Müller M, Raio L, Rovó A.. Acta Haematol. 2023 Oct 13. https://doi.org/10.1159/000533776 Epub
ahead of print. PMID: 37839398.In Vitro-Transfusional Model for Red-Blood-Cell Study: the Advantage of Lowering Hematocrit
Längst E, Crettaz D, Delobel J, Renella R, Bardyn M, Turcatti G, Tissot J-D, and Prudent M
Blood Transfus, 2023, 21, 277-288. https://doi.org/10.2450/2022.0086-22The Effect of the Donor’s and Recipient’s Sex on Red Blood Cells Evaluated Using Transfusion
SimulationsLängst E, Crettaz D, Tissot J-D and Prudent M
Cells, 2023, 12, 1454, 1-14. https://doi.org/10.3390/cells12111454Phosphoproteomics and Morphology of Stored Human Red Blood Cells Treated by ProteinTyrosine-Phosphatases Inhibitor
Bardyn M, Crettaz D, Rappaz B, Hamelin R, Armand F, Tissot J-D, Turcatti G, and Prudent M
Blood Advances, 2023, On-line, https://doi.org/10.1182/bloodadvances.2023009964Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumors
Schmidt J, Chiffelle J, Perez MAS, Magnin M, Bobisse S, Arnaud M, Genolet R, Cesbron J, Barras D,
Navarro Rodrigo B, Benedetti F, Michel A, Queiroz L, Baumgaertner P, Guillaume P, Hebeisen M,
Michielin O, Nguyen-Ngoc T, Huber F, Irving M, Tissot-Renaud S, Stevenson BJ, Rusakiewicz S, Dangaj Laniti D, Bassani-Sternberg M, Rufer N, Gfeller D, Kandalaft LE, Speiser DE, Zoete V, Coukos G, Harari A. Nat Commun. 2023 Jun 6;14(1):3188. https://www.nature.com/articles/s41467-023-38946-zOverall avidity declines in TCR repertoires during latent CMV but not EBV infection
Couturaud B, Doix B, Carretero-Iglesia L, Allard M, Pradervand S, Hebeisen M, Rufer N. Front Immunol. 2023 Nov 20;14:1293090. https://doi.org/10.3389/fimmu.2023.1293090 eCollection 2023.
Understanding the parameters guiding the best practice for treating B-cell-depleted patients with COVID-19 convalescent plasma therapy
Gachoud D, Bertelli C, Rufer N. Br J Haematol. 2023 Jan;200(2):e25-e27. https://doi.org/10.1111/bjh.18540
Epub 2022 Nov 10. Successful outcome of pregnancy post-allogeneic stem cell transplant despite severe RH1 alloimmunization: A case report
Gavillet M, Rufer N, Grandoni F, Rizzi M, Vulliemoz N, Baud D, Alberio L, Canellini G, Legardeur H. Br J Haematol. 2023 May;201(3):581-584. https://doi.org/10.1111/bjh.18741 Epub 2023 Mar 14.
Inborn errors of type I interferon immunity in patients with symptomatic acute hepatitis E
Saadat A, Gouttenoire J, Ripellino P, Semela D, Amar S, Frey BM, Fontana S, Mdawar-Bailly E, Moradpour D, Fellay J, Fraga M; HEV Human Genetics Collaborators: Badini G, Bergamin I, Bernsmeier C, Clerc O, Deibel A, Eichler K, Friedrich N, Sinnreich M F, Gagliarducci E, Gavillet M, Meylan D, Müllhaupt B, Niederhauser C, Rufer N, Schindler E, Zürcher M Hepatology. 2023 Dec 8. https://doi.org/10.1097/HEP.0000000000000701 Online ahead of print.
Abstracts
Neuropathies related to Hepatitis E virus infection in Switzerland: A prospective, matched case-control study
Ripellino P, Lascano AM, Schilg-Hafer L, Scheidegger O, Schreiner B, Tsouni P, Vicino A, Peyer A, Humm A, Décard BF, Pianezzi E, Zezza G, Sparasci D, Hundsberger T, Dietmann A, Jung H, Kuntzer T, Wilder-Smith E, Martinetti-Lucchini G, Fontana S, Niederhauser C, Gobbi C. 9th Congress of the European Academy of Neurology, 2023 Budapest
Immune events preceding neuralgic amyotrophy
Sparasci D, Schilg-Hafer L, Schreiner B, Scheidegger O, Peyer A , Lascano AM, Vicino A, Décard BF, Tsouni P, Humm A, Pianezzi E, Zezzi G, Hundsberger T, Dietmann A, Jung H, Kuntzer T, Wilder-Smith E, Martinetti-Lucchini G, Fontana S, Niederhauser C, Gobbi C, Ripellino P. Peripheral Nerve Society Annual Meeting, 2023 Copenhagen
Analysis of Routine Specificity Data of Roche Diagnostics Infectious Disease Screening Assays for HIV, HBV, HCV, HTLV, Syphilis and Chagas in 6 Blood Screening Centres
Pistorius C, Pietersen N, Cable R, Tinguely C, Niederhauser C, Majchrzak M, Arriaga G, Guillet M. ISBT 2023, 18–21 November, Cape Town
Identification of Three Novel ABO Blood Group Alleles
Lejon Crottet S, Kräuchi R, Niederhauser C, Rüfli T, Mihm B, Levrat E and Henny C, ISBT 2023 Göteborg
sCD38: A soluble protein for mitigation of therapeutic anti-CD38 in the indirect antiglobulin test
Lejon Crottet S, Locher N, Caesar A, Feuerhahn S and Niederhauser C, Swisstransfusion 2023
Implementation of Erytra automated analyser for Blood Group Typing in a Blood Donor Setting: Experience and first results
Tinguely C., Gfeller B., Still F., Lejon Crottet S., Niederhauser C ISBT 2023 Göteborg & Swisstransfusion 2023 als Poster
Prevalence of acute Hepatitis E virus infections in Swiss Blood Donations 2018-2020
Niederhauser C, Gowland P, Widmer N, Amar El Dusouqui S, Mattle M, Gottschalk J, Frey BM. Abstract presented at 33rd Regional Congress of the ISBT, Gothenburg, Sweden, 2023
Anti-SARS-CoV-2 antibody development during the COVID-19 pandemic in Swiss blood donors
Gowland P, Widmer N, Tinguely C, Fontana S, Pehlic V, Thierbach J, Waldvogel Abramowski S, Züger M, Niederhauser C. Abstract presented at 33rd Regional Congress of the ISBT, Gothenburg, Sweden, 2023 and Swisstransfusion Kongress 2023. Rorschach
Two novel alleles harboring a deletion in the KEL and RH blood group system
C Henny, R Kräuchi, C Niederhauser, M Gavillet, T Gleich-Nagel, S Lejon Crottet. Abstract presented at 33rd Regional Congress of the ISBT, Gothenburg, Sweden, 2023
Blood group genotyping in donors of Africant descent
Kräuchi R, Lejon Crottet S, Niederhauser C, Infanti L, T Rüfli T, Henny C Abstract presented at 33rd Regional Congress of the ISBT, Gothenburg, Sweden, 2023
Routine testing for RHD*01W.1, RHD*01W.2 and RHD*01.W3 subtype alleles is dispensable in Switzerland
Schimanski B, Kräuchi R, Lejon Crottet S, Niederhauser C and Henny C Abstract presented at 33rd Regional Congress of the ISBT, Gothenburg, Sweden, 2023
Fetal RHD Screening in RH1 negative pregnant women: Experience in Switzerland
Kräuchi R, Schimanski B, Lejon Crottet S, Niederhauser C, Hodel M, Amylidi S, Raio L and Henny C Abstract presented at 33rd Regional Congress of the ISBT, Gothenburg, Sweden, 2023
Dépistage en routine du VHE RNA depuis octobre 2018 en Suisse
Niederhauser C, Gowland P, Widmer N, Amar El Dussouqui S, Mattle M, Gottschalk J, Frey BM. Transfusion Clinique et Biologique Novembre 2023 SFTS, L15-3, page 516.
Validation data of a hypoxic red blood cell processing and storage system
Martin A, Crettaz D, Bergeron P. Walicka-Philippo I, Prudent M
Poster, ISBT 2023, Gothenburg, Sweden, June 2023
Vox Sanguinis, 2023, 118(Suppl 1), P148. https://doi.org/10.1111/vox.13433Discrimination of agonists-stimulated platelet phenotypes depending on pathogen inactivation and storage temperature in a blood bank
Muret C, Crettaz D, Alberio L, Prudent M
Poster International Society of Thrombosis and Hemostasis (ISTH) 2023, Montreal, Canada, June 2023Optimization of the pooling time during the preparation of platelet concentrates in octopus configuration with a new sterile multiple connection device
Martin A, Muhtari S, Feldmann J, Zehnder M, Benzoni M, Prudent M
Poster, DGTI 2023, Berlin, Germany, Sept. 2023Evaluation d’un nouvel appareil à connexions stériles multiples pour le mélange des Buffy-Coats en configuration Octopus
Martin A, Muhtari S, Feldmann J, Zehnder M, Benzoni M, Prudent M
Poster, SFTS 2023, Toulouse, France, Nov. 2023Analyses phosphoprotéomiques et fonctionnelles des plaquettes traitées par inactivation des pathogènes et conservées à froid ou à température ambiante
Muret C, Crettaz D, Alberio L, Prudent M
Oral presentation, SFTS 2023, Toulouse, France, Nov. 2023Modulation du phosphoprotéome et morphologie des globules rouges stockés
Bardyn M, Crettaz D, Rappaz B, Hamelin R, Armand F, Tissot J-D, Turcatti G, Prudent M
Oral presentation, SFTS 2023, Toulouse, France, Nov. 2023Specific TCR/CDR mutations positively or negatively modulate the functional efficacy of NY-ESO-1-redirected CD8 T cells in a mutually exclusive manner
Doix B, Tardivon D, Duong MM, Vincent K, Zoete V, Hebeisen M and Rufer N
4th International
Transfusion-Transmitted Malaria and Mitigation Strategies in Nonendemic Regions
Niederhauser N, Galel Susan A. Transfus Med Hemother 2022;49:205-216. https://doi.org/10.1159/000525414
Prevalence of anti-tick-borne encephalitis virus (TBEV) antibodies in Swiss blood donors in 2014-2015
Ackermann-Gäumann R, Eyer C, Vock M, Gowland P, Tinguely C, Leib SL, Bori M, Buser A, Fontana S, Thierbach J, Weingand T, Niederhauser C. Blood Transfus 2022; https://doi.org/10.2450/2022.0099-22
Antibody response and intra-host viral evolution after plasma therapy in COVID-19 patients pre-exposed or not to B-cell depleting agents
Gachoud D, Pillonel T, Tsilimidos G, Battolla D, Dumas D, Opota O, Fontana S, Vollenweider P, Manuel O, Greub G, Bertelli C, Rufer N. British J Hematol. 2022; 13:10.111/bjh.18450. https://doi.org/10.1111/bjh.18450
Understanding the parameters guiding the best practice for treating B-cell-depleted patients with COVID-19 convalescent plasma therapy
Gachoud D, Bertelli C, Rufer N. British J Hematol. 2022, in press. https://doi.org/10.1111/bjh.18540
Accès au lait de donneuses en Suisse et création de la première banque de lait maternel romande au CHUV : enjeux et perspectives
Fischer-Fumeaux C, Barin J, Prudent M, C Richard, Martin A, Henriot I, Legardeur H, Kaech C, May H, Vuignier J, Tolsa J-F Rev Med Suisse, 2022, 18, 59-63. https://doi.org/10.53738/revmed.2022.18.764-65.59
Antioxidants in single methylene-blue-treated plasma units cannot be used to predict pathogen inactivation treatment success
Lotens A, Prudent M and A. Rapaille Vox Sanguinis, 2022, 117, 937-942. https://doi.org/10.1111/vox.13273
Effect of mercury on membrane proteins, anionic transport and cell morphology in human erythrocytes
Notariale R, Längst E, Perrone P, Crettaz D, Prudent M and Manna C Cell Physiol Biochem, 2022, 56, 500-513. https://doi.org/10.33594/000000572
A Dynamic Constraint-based Modelling (DCBM) Approach with Alternative Metabolic Objective Functions Predicts The impact of Oxidative Stress
Yasemi M, Prudent M, Jolicoeur M. IFAC PapersOnLine, 2022, 55-20, 385-390. https://doi.org/10.1016/j.ifacol.2022.09.125
Two novel platelet biotinylation methods and their impact on stored platelet concentrates in a blood bank environment
Muret C, Crettaz D, Martin A, Aliotta A, Bertaggia Calderara D, Alberio L and Prudent M Transfusion, 2022, 62, 2324-2333. https://doi.org/10.1111/trf.17129
In Vitro-Transfusional Model for Red-Blood-Cell Study: the Advantage of Lowering Hematocrit
Längst E, Crettaz D, Delobel J, Renella R, Bardyn M, Turcatti G, Tissot J-D, and Prudent M Blood Transfus, 2022, Early view. https://doi.org/10.2450/2022.0086-22
Evolution of Blood Safety in Switzerland over the Last 25 years for HIV, HCV, HBV and Treponema pallidum
Niederhauser C, Tinguely C, Stolz M, Vock M, Amar El Dusouqui S, Gowland P.
Viruses 2022, 14(12), 2611; https://doi.org/10.3390/v14122611 - 23 Nov 2023The Disease Burden of Delta and Omicron Variants of SARS-CoV-2 in a Predominantly Vaccinated and Healthy Cohort
Parham S Branca M, Büchi A, Widmer N, Tande A, Gowland P, and PoliVOV-19 study team. The Disease Burden of Delta and Omicron Variants of SARS-CoV-2 in a Predominantly Vaccinated and Healthy Cohort; Clinical Clin Microbiol Infect. 2022 Sep 3:S1198-743X(22)00456-6. https://doi.org/10.1016/j.cmi.2022.08.019. Online ahead of print.
Serosurveillance after a COVID‐19 vaccine campaign in a Swiss police cohort
Sendi P, Thierstein M, Widmer N, Babongo Bosombo F, Büchi AE, Güntensperger D, Blum MR, Baldan R, Tinguely C, Gahl B, Heg D, Theel ES, Berbari E, Endimiani A, Gowland P, Niederhauser C PoliCOV‐19 study. Immun Inflam and Disease, May 4th 2022, https://doi.org/10.1002/iid3.640
Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients
Purde MT, Niederer R, Wagner NB, Diem S, Berner F, Ali OH, Hillmann D, Bergamin I, Joerger M, Risch M, Niederhauser C, LenzTL, Früh M, Risch L, Semela D, Flatz L. J Cancer Res Clin Oncol. 2022 Mar;148(3):647-656. https://doi.org/10.1007/s00432-021-03870-6 Epub 2021 Dec 7.